Implications of circulating chromogranin A in prostate cancer

By Hirano Daisaku   Minei Sadatsugu   Sugimoto Shuji   Yamaguchi Kenya   Yoshikawa Tetsuo   Hachiya Takahiko   Kawata Nozomu   Yoshida Toshio   Takahashi Satoru  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 4, 2007-09 ,pp. : 297-301

Informa Healthcare

Access to resources Recommend Favorite

p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis

By Parsons J.K.   Gage W.R.   Nelson W.G.   De Marzo A.M.  

Urology, Vol. 58, Iss. 4, 2001-10 ,pp. : 619-624

Elsevier

Access to resources Recommend Favorite

Loss of maspin expression in prostate cancer induced by a P53- and HER-2- pathway/overexpression profiling by whole-mount derived tissue microarrays

By Merseburger A.   Kuczyk M.   David M.   Moul J.   Sesterhenn I.   Jonas U.   Mostofi F.   Srivaslava S.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 61-61

Elsevier

Access to resources Recommend Favorite

Osteoprotegerin and rank ligand expression in prostate cancer

By Brown J.M.   Corey E.   Lee Z.D.   True L.D.   Yun T.J.   Tondravi M.   Vessella R.L.  

Urology, Vol. 57, Iss. 4, 2001-04 ,pp. : 611-616

Elsevier

Access to resources Recommend Favorite

Insulin-like growth factor I and prostate cancer

By O'Brien M.F.   Watson R.W.G.   Fitzpatrick J.M.  

Urology, Vol. 58, Iss. 1, 2001-07 ,pp. : 1-7

Elsevier

Access to resources Recommend Favorite